Directory

Directory

Tan-Koi Wei Chuen

Assistant Professor, Centre of Regulatory Excellence

weichuen.tankoi@duke-nus.edu.sg

65161679

About

Professional

Research Interests

Teaching

Publications

Bio

Dr. Tan-Koi leads international regulatory systems strengthening initiatives in vaccine and diagnostics regulation under projects commissioned by the Asian Development Bank and the Gates Foundation. She has served as faculty for the ASEAN Vaccine Security and Self-Reliance capacity building programme and the Asia-Pacific Economic Cooperation (APEC) Pharmacovigilance Centre of Excellence Pilot Programme. With over 15 years of experience across a national regulatory agency, consulting engagements and international technical assistance projects, Dr. Tan-Koi focuses on policy innovation and regulatory science to advance equitable access to safe, effective and quality-assured biomedical innovations.

Prior to her current appointment, Dr. Tan-Koi was Regulatory Consultant at the Health Sciences Authority of Singapore, where she also served as Team Lead for the Regulatory Research (Pharmacogenomics) and Risk Communication teams. Trained in pharmacy at the National University of Singapore, Dr. Tan-Koi practised for over a decade in KK Women's and Children's Hospital. She holds a PhD from the National University of Singapore Saw Swee Hock School of Public Health and is a recipient of the Singapore Ministry of Health (MOH) Health Manpower Development Plan (HMDP) Fellowship (Graduate Research Programme in Public Health).

Education

Doctor of Philosophy

National University of Singapore, Singapore

Professional Appointment(s)

Regulatory Consultant and Team Lead of the Risk Communication and Regulatory Research Unit;

Health Sciences Authority, 01/2008 - 10/2019

Content Expert

Lee Kong Chian School of Medicine, Nanyang Technological University, 01/2016 - 12/2019

Lecturer

National Collaborative Prescribing Program, National University of Singapore, 01/2018 - 12/2018

Membership

Member

Pharmacy Society of Singapore, Currently Active

Voting Delegate

US Pharmacopoeia (USP), Currently Active

Research Interests

Dr Tan-Koi's research in health policy and regulatory science examines approaches to facilitate equitable and timely access to safe, effective, and quality-assured biomedical innovations for precision medicine, infectious diseases, and maternal and child health. Her work is disseminated through peer-reviewed manuscripts, book chapters, policy briefs, and market insight reports.

Main Research Areas

• Health policy innovation — Examine policy levers to accelerate timely access to biomedical innovations at the health-system level, with particular emphasis on vaccines, diagnostics, and genetic tests.

• Regulatory systems strengthening — Develop approaches to enhance regulatory capacity and systems strengthening, with a focus on low resourced settings.

• Evidence-to-practice translation — Advance the uptake of research evidence into regulatory and public health policy, including tailored approaches for genetic testing, post-market safety surveillance, and regulator–patient engagement.

Teaching

Faculty member of international workshops and post-graduate education.

• ASEAN Vaccine Security and Self-Reliance (AVSSR): Vaccine Human Resource Development Program for Enhancing Vaccine Development and Deployment Capacities in ASEAN Countries

• Duke-NUS Medical School Centre of Regulatory Excellence Graduate Certificate

• Duke-NUS Medical School Masters of International Translational Medicine

• NUS Yong Loo Lin School of Medicine Master of Science in Precision Health & Medicine

• NUS Yong Loo Lin School of Medicine Master of Science in Applied Biomedicine

Publications

Regulatory factors affecting sustainable vaccine manufacturing in Asia and the Pacific: Findings from a scoping review and semi-structured interviews.

Vaccine – Chan Mei Xuan Jessalyn; Khoo Yoong Khean; Stona Anne-Claire; Joarder Taufique; de Alwis Ruklanthi; Vogel Silke; Lim John C W; Tan-Koi Wei Chuen (2025)

63 127607-N.A

Directory

Bio

Education

Doctor of Philosophy

Professional Appointment(s)

Regulatory Consultant and Team Lead of the Risk Communication and Regulatory Research Unit;

Content Expert

Lecturer

Membership

Member

Voting Delegate

Research Interests

Teaching

Publications

Regulatory factors affecting sustainable vaccine manufacturing in Asia and the Pacific: Findings from a scoping review and semi-structured interviews.

Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspective.

Regulation in the age of calamity: Changing the regulatory paradigm.

Regulatory Strengthening as a Pillar of Health System Resilience for Sustainable Immunization.

Promoting collaboration of regulators and patients in improving drug safety and regulatory decision making.

Pandemic Vaccine Development

Enhancing Vaccine Regulation for Pandemic Preparedness

Ensuring Sustainable, Locally Relevant Vaccine R&D in Resource-Limited Settings

Pharmacovigilance activities in ASEAN countries.

Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.

Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore.

Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.

Applications of pharmacogenomics in regulatory science: a product life cycle review.

Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.

Post-vaccination abscess requiring surgical drainage in a tertiary children's hospital in Singapore.

Is HLA-B*58:01 genotyping cost effective in guiding allopurinol use in gout patients with chronic kidney disease?

The importance of ethnicity definitions and pharmacogenomics in ethnobridging and pharmacovigilance

A cluster of Epoetin-associated pure red cell aplasia: clinical features and the possible association of HLA-DRB1*12:02.

Pharmacogenetics through a public health lens: from policy to practice.

Browser not supported

Modern websites need modern browsers